I Am BiotechOvjeren akaunt

@IAmBiotech

I Am Biotech is where biotech professionals and enthusiasts can come together and discuss the promise of biotech innovation.

Washington, DC
Vrijeme pridruživanja: siječanj 2009.

Tweetovi

Blokirali ste korisnika/cu @IAmBiotech

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @IAmBiotech

  1. First childhood helps explain why virus hits some people harder than others

    Poništi
  2. Coming soon at : Speaker Dr. Benjamin Cowen, of ImmunoMet, a clinical-stage company developing anti-tumor and immune-metabolism therapies. Here's an early look:

    Poništi
  3. ". . . the international reference pricing is “not the right way” to lower prescription drugs costs and calls on the president to ensure America continues to lead the world in biomedical innovation," says Rachel King, co-founder and CEO of GlycoMimetics:

    Poništi
  4. BIG NEWS: BIO World Congress Is Now BIO IMPACT -- here's the full story:

    Poništi
  5. Sign up for the BIO Boardlist to support our mission of promoting workforce development, , and at

    Poništi
  6. 5. velj

    can help us win in the fight against and America’s biopharmaceutical companies are leading the charge.

    Poništi
  7. 5. velj

    Despite the rhetoric from politicians in Washington, national data shows retail drug costs are NOT skyrocketing – just look at ’s own data:

    Poništi
  8. 5. velj

    Adopting foreign price controls “prevents investors from being able to invest, and inventors from being able to invent.” Our full statement:

    Poništi
  9. 4. velj

    The Message We Hope President Trump Will Convey During His State of the Union Address from

    Poništi
  10. 4. velj

    Meet ImmunoMet’s Dr. Benjamin Cowen, Speaker at

    Poništi
  11. 4. velj

    Download your copy of BIO’s first annual report on and in at

    Poništi
  12. 4. velj

    On —instead of celebrating new treatments, policymakers continue to promote controls that would harm future cures. VIDEO: how an international price index would have an “absolutely chilling” effect on investments in risky cures.

    Poništi
  13. 4. velj

    For nearly 2 decades, the BIO World Congress has been a catalyst for the growth of the biobased economy. But to better represent the influence biotech innovation has across sectors, today we are unveiling a new name: BIO IMPACT Ag & Environment Conference.

    Poništi
  14. 4. velj

    Find out the 4 key ways is helping achieve the UN Development Goals:

    Poništi
  15. 4. velj
    Poništi
  16. 4. velj

    is a Shared Goal; Should be a Shared Solution

    Poništi
  17. 4. velj

    Antibody Screening Technology Is Never Out of Sorts

    Poništi
  18. 3. velj

    ICYMI: WHO declares Wuhan 2019-nCoV a global health emergency

    Poništi
  19. 3. velj

    Proxy firms have outsized market influence, and their opaque standards, one-size-fits-all recommendations, and conflicts of interest negatively impact emerging biotech companies. Read BIO’s comment letter to the SEC on improving proxy firm transparency.

    Poništi
  20. 3. velj

    In the UK, £20m announced to fund for and other infectious diseases

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·